Sonder Capital

Neptune Medical is a venture capital-backed start-up focused on the development, manufacturing, and commercialization of innovative single-use medical devices for gastroenterology. The company specializes in creating high-volume devices that enhance the precision and safety of minimally invasive procedures. One of its notable products offers advanced tip control that allows the endoscope tip to maneuver effectively within the anatomy, enabling seamless scope exchanges without the risk of kinks or luminal collapse. This design not only accelerates procedures but also reduces anesthesia time and improves overall patient comfort. Neptune Medical's proprietary technologies aim to improve patient outcomes and provide greater flexibility and ease of use for surgeons and medical professionals in various endoscopic applications.

Jupiter Endovascular is a medical technology startup specializing in innovative endovascular procedures. Their flagship product, the Endoportal device, navigates flexibly through blood vessels via minimally invasive percutaneous access. Once positioned, it stabilizes to deliver precise interventional treatments, mimicking the control and precision of direct surgical access but from an endovascular approach. This technology aims to enhance catheter-based interventions by overcoming traditional limitations.

Vitestro is a developer of innovative medical robotic devices focused on enhancing patient care through autonomous blood drawing technology. The company's flagship device employs multi-dimensional ultrasound detection to identify nerves and arteries, utilizing deep learning algorithms to minimize the risk of arterial complications during clinical procedures. This advancement aims to streamline the blood collection process in hospitals and clinical laboratories, ultimately enabling healthcare professionals to perform operations with greater precision and improve overall patient health outcomes.

Vitestro is a developer of innovative medical robotic devices focused on enhancing patient care through autonomous blood drawing technology. The company's flagship device employs multi-dimensional ultrasound detection to identify nerves and arteries, utilizing deep learning algorithms to minimize the risk of arterial complications during clinical procedures. This advancement aims to streamline the blood collection process in hospitals and clinical laboratories, ultimately enabling healthcare professionals to perform operations with greater precision and improve overall patient health outcomes.

Wondr Medical is a London-based company established in 2016 that operates a platform designed to connect health professionals worldwide. Its primary objective is to enhance discovery, innovation, and collaboration within the global health network. The platform facilitates the generation of new ideas and the expansion of professional networks, while also aiding in the discovery of medical events and job opportunities. By providing a space for professional teams to share their work and stay informed, Wondr Medical aims to streamline communication and collaboration among medical professionals, ultimately advancing the field of healthcare.

G.I. Windows, Inc. is a clinical-stage company based in West Bridgewater, Massachusetts, founded in 2012. The company specializes in manufacturing medical devices utilizing advanced surgical anastomotic technology aimed at treating obesity and type 2 diabetes. G.I. Windows is focused on developing innovative solutions that enable less invasive surgical procedures, thereby creating a new category in healthcare. Its technology is designed to enhance the efficiency of diagnostic and interventional procedures, ultimately improving patient outcomes while reducing overall healthcare costs.

Avail Medsystems, Inc. is a digital healthcare company based in Palo Alto, California, that specializes in developing a comprehensive hardware and software platform designed to connect healthcare professionals remotely. The company offers a fully integrated audio/visual system that facilitates real-time collaboration and procedural support, enabling practitioners to access clinical expertise and education without the constraints of physical location. By democratizing access to specialized knowledge and services, Avail Medsystems enhances the efficiency of healthcare delivery and promotes the adoption of innovative medical technologies. Founded in 2012 and previously known as Nurep, Inc., the company aims to improve patient care by bridging gaps between healthcare providers and medical technology experts.

Mechanodontics, Inc. is a Dallas, Texas-based company established in 2016 that specializes in the manufacture of a discreet dental device designed to move teeth independently. This innovative method serves as an alternative to traditional braces and aligners, offering significant advantages such as reduced treatment time, improved ease of cleaning, and enhanced comfort. The device is placed behind the teeth, making it virtually invisible, and is engineered to work on each tooth individually, allowing for more precise adjustments.

G.I. Windows, Inc. is a clinical-stage company based in West Bridgewater, Massachusetts, founded in 2012. The company specializes in manufacturing medical devices utilizing advanced surgical anastomotic technology aimed at treating obesity and type 2 diabetes. G.I. Windows is focused on developing innovative solutions that enable less invasive surgical procedures, thereby creating a new category in healthcare. Its technology is designed to enhance the efficiency of diagnostic and interventional procedures, ultimately improving patient outcomes while reducing overall healthcare costs.

Potrero Medical, Inc. is a predictive health company that specializes in developing advanced monitoring devices to detect subtle changes in physiological parameters. The company's products are designed to provide early warnings of conditions such as sepsis and systemic inflammatory response syndrome, while also optimizing treatment by detecting and preventing fluid overload during resuscitation efforts. Potrero Medical's devices monitor various metrics, including intra-abdominal pressure, core body temperature, heart rate, respiratory rate, relative cardiac output, and urine output. Founded in 2011 and based in San Francisco, California, the company aims to leverage smart sensors and artificial intelligence to enhance the ability of medical teams to predict adverse outcomes in critical care environments.